Abstract

The value of the HER2DX genomic assay in patients with advanced HER2+ disease is currently unknown. Here, we evaluated the association of the information provided by the HER2DX assay with T-DM1 benefit and survival.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call